SEC Form 4 · accession 0001654954-18-001720
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Mehmood Khan
Director
Period of report
Feb 16, 2018
Accepted (ET)
Feb 20, 2018 · 4:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 452,083 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Common Stock)F1 | $0.57 | Feb 16, 2018 | A | 40,000 | A | — | Feb 16, 2028 | Common Stock | 40,000 | 40,000 | D |
| Restricted Stock UnitsF2 | — | Feb 16, 2018 | A | 10,000 | A | — | — | Common Stock | 10,000 | 10,000 | D |
| Restricted Stock UnitsF2 | — | Feb 16, 2018 | A | 2,500 | A | — | — | Common Stock | 2,500 | 2,500 | D |
| Stock Option (Right to Buy Common Stock)F3 | $0.45 | holding | — | — | — | — | Jun 25, 2027 | Common Stock | 75,000 | 75,000 | D |
Explanation of responses
- F1These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F2These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F3These options were granted on 6/25/2017. These options vest 1/3 on the date of grant, 1/3 on the first anniversary of the date of grant and 1/3 on the second anniversary of the date of grant.